Tirzepatide – 20mg

Tirzepatide – 20mg
Dual GIP / GLP-1 Receptor Agonist

Biovexa Tirzepatide is a 39-amino-acid synthetic peptide that acts as a dual agonist at both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. In preclinical models it is studied for its effects on appetite regulation, glycemic control and energy expenditure — with the GIP activity that distinguishes it from single-incretin analogs.

Key research focus: Dual incretin receptor pharmacology, appetite and metabolic pathways, body-composition models.

Form: Lyophilized powder — ≥99% purity (HPLC)
Content: 20mg per 3ml vial
Storage: Store at 2–8 °C, protected from light
Origin: Made in USA

For research use only. Not for human or animal consumption. Not a drug, food, supplement or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. Qualified researchers only. See our Research Use Policy.